argenx SE (ARGX) stock
ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$981.33+3.75 (+0.38%)
Close on Nov 12, 2026Market cap –P/E 50.1Yield –
argenx operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2023 it was -1196.2%, against -7184.7% the year before. The highest annual figure on record is -70.1% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -1196.2% | +5988.5 |
| FY2022 | Dec 31, 2022 | -7184.7% | −7114.6 |
| FY2021 | Dec 31, 2021 | -70.1% | +1087.9 |
| FY2020 | Dec 31, 2020 | -1158.1% | −904.6 |
| FY2019 | Dec 31, 2019 | -253.5% | +127.5 |
| FY2018 | Dec 31, 2018 | -381.0% | – |
See a number that looks wrong?